Annual EBITDA
-$484.39 M
+$337.95 M+41.10%
December 31, 2024
Summary
- As of March 10, 2025, DNA annual EBITDA is -$484.39 million, with the most recent change of +$337.95 million (+41.10%) on December 31, 2024.
- During the last 3 years, DNA annual EBITDA has risen by +$1.32 billion (+73.19%).
- DNA annual EBITDA is now -354.15% below its all-time high of -$106.66 million, reached on December 31, 2019.
Performance
DNA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$143.48 M
-$108.40 M-308.95%
December 31, 2024
Summary
- As of March 10, 2025, DNA quarterly EBITDA is -$143.48 million, with the most recent change of -$108.40 million (-308.95%) on December 31, 2024.
- Over the past year, DNA quarterly EBITDA has stayed the same.
- DNA quarterly EBITDA is now -680.10% below its all-time high of -$18.39 million, reached on September 30, 2021.
Performance
DNA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$484.39 M
+$146.45 M+23.21%
December 31, 2024
Summary
- As of March 10, 2025, DNA TTM EBITDA is -$484.39 million, with the most recent change of +$146.45 million (+23.21%) on December 31, 2024.
- Over the past year, DNA TTM EBITDA has stayed the same.
- DNA TTM EBITDA is now -1797.50% below its all-time high of -$25.53 million, reached on September 30, 2020.
Performance
DNA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
DNA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +41.1% | 0.0% | 0.0% |
| 3 y3 years | +73.2% | 0.0% | 0.0% |
| 5 y5 years | -354.1% | 0.0% | 0.0% |
DNA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +76.7% | -308.9% | +91.5% | at high | +86.7% |
| 5 y | 5-year | -354.1% | +76.7% | -680.1% | +91.5% | -1797.5% | +86.7% |
| alltime | all time | -354.1% | +76.7% | -680.1% | +91.5% | -1797.5% | +86.7% |
Ginkgo Bioworks Holdings EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$484.39 M(-41.1%) | -$143.48 M(+308.9%) | -$484.39 M(-23.2%) |
| Sep 2024 | - | -$35.09 M(-75.1%) | -$630.84 M(-17.5%) |
| Jun 2024 | - | -$140.69 M(-14.8%) | -$764.88 M(-3.3%) |
| Mar 2024 | - | -$165.13 M(-43.0%) | -$790.69 M(-3.8%) |
| Dec 2023 | -$822.34 M(-60.4%) | -$289.93 M(+71.4%) | -$822.34 M(+24.6%) |
| Sep 2023 | - | -$169.12 M(+1.6%) | -$659.95 M(-42.0%) |
| Jun 2023 | - | -$166.50 M(-15.4%) | -$1.14 B(-29.3%) |
| Mar 2023 | - | -$196.79 M(+54.3%) | -$1.61 B(-22.6%) |
| Dec 2022 | -$2.08 B | -$127.54 M(-80.3%) | -$2.08 B(-42.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$647.02 M(+1.5%) | -$3.64 B(+20.9%) |
| Jun 2022 | - | -$637.75 M(-4.3%) | -$3.01 B(+24.2%) |
| Mar 2022 | - | -$666.43 M(-60.4%) | -$2.42 B(+32.8%) |
| Dec 2021 | -$1.81 B(+1563.8%) | -$1.68 B(+9055.7%) | -$1.82 B(+903.3%) |
| Sep 2021 | - | -$18.39 M(-65.2%) | -$181.80 M(-3.8%) |
| Jun 2021 | - | -$52.78 M(-23.3%) | -$188.94 M(+38.8%) |
| Mar 2021 | - | -$68.83 M(+64.7%) | -$136.16 M(+102.2%) |
| Dec 2020 | -$108.58 M(+1.8%) | -$41.80 M(+63.7%) | -$67.33 M(+163.7%) |
| Sep 2020 | - | -$25.53 M | -$25.53 M |
| Dec 2019 | -$106.66 M | - | - |
FAQ
- What is Ginkgo Bioworks Holdings annual EBITDA?
- What is the all time high annual EBITDA for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings annual EBITDA year-on-year change?
- What is Ginkgo Bioworks Holdings quarterly EBITDA?
- What is the all time high quarterly EBITDA for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings quarterly EBITDA year-on-year change?
- What is Ginkgo Bioworks Holdings TTM EBITDA?
- What is the all time high TTM EBITDA for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings TTM EBITDA year-on-year change?
What is Ginkgo Bioworks Holdings annual EBITDA?
The current annual EBITDA of DNA is -$484.39 M
What is the all time high annual EBITDA for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high annual EBITDA is -$106.66 M
What is Ginkgo Bioworks Holdings annual EBITDA year-on-year change?
Over the past year, DNA annual EBITDA has changed by +$337.95 M (+41.10%)
What is Ginkgo Bioworks Holdings quarterly EBITDA?
The current quarterly EBITDA of DNA is -$143.48 M
What is the all time high quarterly EBITDA for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high quarterly EBITDA is -$18.39 M
What is Ginkgo Bioworks Holdings quarterly EBITDA year-on-year change?
Over the past year, DNA quarterly EBITDA has changed by $0.00 (0.00%)
What is Ginkgo Bioworks Holdings TTM EBITDA?
The current TTM EBITDA of DNA is -$484.39 M
What is the all time high TTM EBITDA for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high TTM EBITDA is -$25.53 M
What is Ginkgo Bioworks Holdings TTM EBITDA year-on-year change?
Over the past year, DNA TTM EBITDA has changed by $0.00 (0.00%)